Lung Cancer News and Research

Latest Lung Cancer News and Research

Whole brain radiotherapy offers no quality-of-life benefit in lung cancer patients with brain metastases

Whole brain radiotherapy offers no quality-of-life benefit in lung cancer patients with brain metastases

HIF-2 inhibitors could be promising target to combat kidney cancer

HIF-2 inhibitors could be promising target to combat kidney cancer

Study collects data on 30-day mortality for breast, lung cancer patients after SACT to improve patient care

Study collects data on 30-day mortality for breast, lung cancer patients after SACT to improve patient care

Research findings could lead to new biomarker for early stages of tumor development

Research findings could lead to new biomarker for early stages of tumor development

Study shows children present at home did not motivate parents to test for radon and tobacco smoke

Study shows children present at home did not motivate parents to test for radon and tobacco smoke

New NCCN Imaging AUC released for eight new cancers

New NCCN Imaging AUC released for eight new cancers

The evolution of medical imaging – where will innovation take us next?

The evolution of medical imaging – where will innovation take us next?

New genetic markers linked to fast rate of nicotine metabolism in smokers may raise risk for lung cancer

New genetic markers linked to fast rate of nicotine metabolism in smokers may raise risk for lung cancer

Three like-minded nonprofits collaborate to launch immunotherapy clinical trial for pediatric brain tumors

Three like-minded nonprofits collaborate to launch immunotherapy clinical trial for pediatric brain tumors

Study shows lymph node stage may have clinical importance among NSCLC patients with M1a disease

Study shows lymph node stage may have clinical importance among NSCLC patients with M1a disease

Researchers identify tantalizing target in fight against aggressive form of lung cancer

Researchers identify tantalizing target in fight against aggressive form of lung cancer

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Checkpoint inhibitor for treatment of NSCLC patients shows indication of added benefit

Added benefit of lung cancer drug not proven, says IQWiG

Added benefit of lung cancer drug not proven, says IQWiG

Study highlights racial/ethnic disparities in genomic sequencing

Study highlights racial/ethnic disparities in genomic sequencing

Moffitt research underscores importance of continued lung cancer screening in high-risk patients

Moffitt research underscores importance of continued lung cancer screening in high-risk patients

Computers could be more accurate than pathologists in assessing lung cancer tissues, study shows

Computers could be more accurate than pathologists in assessing lung cancer tissues, study shows

Study shows leptomeningeal metastases more prevalent in NSCLC patients with EGFR mutations

Study shows leptomeningeal metastases more prevalent in NSCLC patients with EGFR mutations

Cutting off fuel to cancer cells may be potential therapeutic strategy for Kras-driven lung cancers

Cutting off fuel to cancer cells may be potential therapeutic strategy for Kras-driven lung cancers

Economic crisis linked to cancer mortality increase? An interview with Dr Mahiben Maruthappu

Economic crisis linked to cancer mortality increase? An interview with Dr Mahiben Maruthappu

Immunotherapy innovations in oncology: an interview with Robert LaCaze

Immunotherapy innovations in oncology: an interview with Robert LaCaze

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.